Your search returned 13 results.

Results
	1.	The COX-2 selective inhibitor, valdecoxib, does not impair platelet function in the elderly: results of a randomized controlled trial. [electronic resource] by Leese, Philip T Recker, David P Kent, Jeffrey D Producer: 20030818 In: Journal of clinical pharmacology vol. 43 Availability: No items available. Save to lists Add to cart (remove)
	2.	Twenty-Five Years' Experience and Beyond with Cultured Epidermal Autografts for Coverage of Large Burn Wounds in Adult and Pediatric Patients, 1989-2015. [electronic resource] by Hickerson, William L Remmers, Ann E Recker, David P Producer: 20200612 In: Journal of burn care & research : official publication of the American Burn Association vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty. [electronic resource] by Camu, Frederic Beecher, Tessa Recker, David P Verburg, Kenneth M Producer: 20020221 In: American journal of therapeutics vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen. [electronic resource] by Makarowski, W Zhao, William W Bevirt, Terry Recker, David P Producer: 20020513 In: Osteoarthritis and cartilage vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Valdecoxib does not impair platelet function. [electronic resource] by Leese, Philip T Talwalker, Sheela Kent, Jeffrey D Recker, David P Producer: 20020724 In: The American journal of emergency medicine vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis. [electronic resource] by Kivitz, Alan Eisen, Glenn Zhao, William W Bevirt, Terry Recker, David P Producer: 20020816 In: The Journal of family practice vol. 51 Availability: No items available. Save to lists Add to cart (remove)
	7.	The analgesic efficacy of valdecoxib vs. oxycodone/acetaminophen after oral surgery. [electronic resource] by Daniels, Stephen E Desjardins, Paul J Talwalker, Sheela Recker, David P Verburg, Kenneth M Producer: 20020820 In: Journal of the American Dental Association (1939) vol. 133 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	A single preoperative oral dose of valdecoxib, a new cyclooxygenase-2 specific inhibitor, relieves post-oral surgery or bunionectomy pain. [electronic resource] by Desjardins, Paul J Shu, Vincent S Recker, David P Verburg, Kenneth M Woolf, Clifford J Producer: 20020924 In: Anesthesiology vol. 97 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Valdecoxib is more efficacious than rofecoxib in relieving pain associated with oral surgery. [electronic resource] by Fricke, James Varkalis, John Zwillich, Sam Adler, Rebecca Forester, Eliot Recker, David P Verburg, Kenneth M Producer: 20020628 In: American journal of therapeutics vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea. [electronic resource] by Daniels, Stephen E Talwalker, Sheela Torri, Sarah Snabes, Michael C Recker, David P Verburg, Kenneth M Producer: 20020822 In: Obstetrics and gynecology vol. 100 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	The COX-2 specific inhibitor, valdecoxib, is an effective, opioid-sparing analgesic in patients undergoing total knee arthroplasty. [electronic resource] by Reynolds, Lowell W Hoo, Robert K Brill, Robert J North, Janine Recker, David P Verburg, Kenneth M Producer: 20030402 In: Journal of pain and symptom management vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis. [electronic resource] by Sikes, David H Agrawal, Naurang M Zhao, William W Kent, Jeffrey D Recker, David P Verburg, Kenneth M Producer: 20030228 In: European journal of gastroenterology & hepatology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. [electronic resource] by Hansel, Trevor T Kharitonov, Sergei A Donnelly, Louise E Erin, Edward M Currie, Mark G Moore, William M Manning, Pamela T Recker, David P Barnes, Peter J Producer: 20030717 In: FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)